Delivery Order SPE2DR25D2005-SPE2DR26FE6P7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,949.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,815.09 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,721.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,325.30 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract. This competitively awarded, non-set-aside order was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,883.17 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and specifies performance at the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,617.74 for the supply of Jardiance 10 mg tablets (30-count units) under a firm fixed-price contract. The award was made on November 7, 2025, with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $14,267.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,113.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This delivery order carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,578.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $10,075.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this order under its larger...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6P7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,873.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The SPE2DX IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The delivery order for Jardiance, a diabetes medication, exemplifies the company's role in fulfilling routine pharmaceutical supply needs for federal military and veteran healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 11/10/25 |